Andrew D’Amico, serving as a director for VICOR CORP (NASDAQ:VICR), completed a transaction on June 22, 2026, resulting in the disposition of 1,216 shares of the company's common stock. The aggregate proceeds from this sale reached approximately $438,702. The execution of these sales was facilitated by a Rule 10b5-1 trading plan, which Mr. D’Amico originally adopted on September 12, 2024. Prior to the sale, Mr. D’Amico exercised options to acquire an identical quantity of shares on the same date.
The shares were divested at prices fluctuating between $354.12 and $367.10 per unit. Following the conclusion of these transactions, Mr. D’Amico’s direct holding of VICOR CORP common stock stands at zero shares. This divestment occurs against the backdrop of a substantial appreciation in the company's equity, which has appreciated by more than 640% over the preceding twelve-month period. The stock currently commands a price-to-earnings ratio of 111.85. Independent analysis suggests the equity is trading at a premium relative to its estimated fair value, positioning it among stocks identified for overvaluation scrutiny.
Concurrent with the sale, Mr. D’Amico acquired 1,216 shares through the exercise of non-qualified stock options. The exercise price for these options was established at $32.89 per share, culminating in a total exercise cost of $39,994. Furthermore, on the same date, June 22, 2026, Mr. D’Amico received a grant of 548 additional non-qualified stock options. These new grants carry an exercise price of $365.53 per share and were issued under the company’s Amended and Restated 2000 Stock Option and Incentive Plan. The vesting schedule for these options spans a five-year duration, with an expiration date set for June 22, 2036.
The timing of these insider movements aligns with a period of robust operational results for Vicor Corporation. The company reported first-quarter 2026 earnings per share of $0.44, surpassing analyst consensus estimates of $0.37. Revenue for the quarter totaled $112.97 million, representing a 3.59% exceedance of forecasts. Management subsequently upgraded its second-quarter revenue guidance, increasing the projection from $126 million to $142 million. This revision was attributed to growth in product revenues and royalties generated from a new patent license agreement. The agreement provides an original equipment manufacturer with an all-inclusive license to Vicor’s patented power system technology.
Market analysts responded to these developments with revised valuations. Needham elevated its price target for Vicor to $350, citing the increased revenue guidance, and later adjusted the target further to $400, reflecting an optimistic outlook on revenue trajectories. Additionally, the company’s shareholders approved executive compensation and elected eleven directors during the annual meeting.
- Key Point 1: Insider divestment by director Andrew D’Amico occurs after a 640% stock surge, raising valuation questions despite strong fundamentals.
- Key Point 2: Vicor’s Q1 2026 financials exceeded expectations, with EPS of $0.44 and revenue of $112.97 million, driving analyst upgrades.
- Key Point 3: The power electronics sector sees continued momentum as Vicor leverages patented technology for new licensing revenue streams.
- Risk 1: The stock’s elevated P/E ratio of 111.85 and overvaluation metrics suggest potential downside if growth expectations are not met.
- Risk 2: Heavy reliance on patent licensing and revenue guidance revisions introduces uncertainty regarding sustained profitability in the power systems market.